The Valley Desk

NCT00062699 · Interventional trial

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

Overall registry status Terminated

Phase 4

Conditions End-Stage Kidney Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov